CEACAM6 and non-small cell lung carcinoma: To assess the prevalence of CEACAM6 expression and corresponding L-DOS47 binding in NSCLC, we stained and scored serial sections of a commercially available TMA using the PS2+ scoring system adopted from folate receptor alpha (38).